Slide Stainers Market worth $7.39 billion by 2031 - Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Nov. 5, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Slide Stainers Market is projected to reach USD 7.39 billion by 2031 from USD 5.15 billion in 2026, at a CAGR of 7.5% during the forecast period.

Browse 200 market data Tables and 55 Figures spread through 250 Pages and in-depth TOC on "Slide Stainers Market- Global Forecast to 2031"

Slide Stainers Market Size & Forecast:

• Market Size Available for Years: 2026–2031
• 2026 Market Size: USD 5.15 billion
• 2031 Projected Market Size: USD 7.39 billion
• CAGR (2026–2031): 7.5%

Slide Stainers Market Trends & Insights:

• North America accounted for the largest market share in 2025.
• By product, the reagents and kits segment accounted for 65% of the market in 2025.
• By technology, the immunohistochemistry (IHC) is expected to register the highest CAGR of 8.5%.
• By application, the disease diagnostic is expected to register the highest CAGR of 8.0%.
• By end user, the hospitals and diagnostic laboratories segment is expected to register the highest CAGR of 8.5%.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134046412

The market is experiencing steady growth, driven by the rising prevalence of cancer, infectious diseases, and chronic disorders, along with increasing demand for accurate histopathology and cytology diagnostics. Rising volumes of tissue biopsies, blood smear examinations, and pathological testing are accelerating the adoption of automated slide staining systems across hospitals, diagnostic laboratories, and research institutions. Growing emphasis on early disease detection and expanding diagnostic infrastructure are further supporting market growth.

Technological advances in automated and high-throughput slide-staining systems are improving staining consistency, diagnostic accuracy, and laboratory productivity while reducing manual intervention and turnaround times. The growing integration of digital pathology solutions, laboratory information systems (LIS), and automated staining workflows is further driving market adoption. North America and Europe remain major markets, supported by established diagnostic infrastructure. At the same time, Asia-Pacific is expected to see significant growth, supported by rising healthcare investments, expanding pathology laboratories, and increasing diagnostic testing volumes.

The reagents and kits segment holds the major share in the slide stainer market in 2025.

By product, the slide stainer market is segmented into reagents and kits (stains, blocking serum and reagents, diluents and buffers, mounting media, fixative reagents, embedding media, probes, and antibodies), equipment (automated and semi-automated slide stainers and manual slide-staining sets), and consumables and accessories. The reagents and kits segment held the largest share of the slide stainer market in 2025. The reagents and kits segment is experiencing steady growth, supported by the development of specialized staining formulations, expanding applications of multiplex immunohistochemistry (IHC), and growing demand for biomarker-specific diagnostic assays. The shift toward precision medicine and personalized cancer treatment is encouraging laboratories to adopt advanced antibody-based staining kits and companion diagnostic reagents for accurate biomarker identification. Manufacturers are increasingly developing stable, pre-validated reagent formulations, multiplex staining kits, and environmentally sustainable staining solutions to improve diagnostic reproducibility and reduce chemical waste. Additionally, the growing adoption of closed-system reagent platforms, increasing demand for high-sensitivity detection kits, and advancements in reagent compatibility across automated staining instruments are creating new revenue opportunities. The expansion of molecular pathology applications and growing utilization of tissue-based biomarker testing in clinical trials are further supporting segment growth globally.

The hematoxylin & EOSIN (H&E) segment accounted for a significant share of the slide stainer market in 2025.

By technology, the slide stainer market is segmented into hematoxylin & eosin (H&E), immunohistochemistry (IHC), in situ hybridization (ISH), cytology, microbiology, hematology, and special staining. The hematoxylin & eosin (H&E) segment held the largest share of the slide stainer market in 2025. The H&E segment is experiencing steady growth, supported by rising demand for high-quality tissue visualization, advances in automated staining technologies, and a growing emphasis on standardized histological staining protocols. Manufacturers are developing rapid H&E staining solutions, xylene-free staining reagents, and environmentally sustainable formulations to minimize chemical exposure and improve laboratory safety. The increasing adoption of integrated staining and coverslipping platforms, continuous workflow processing, and optimized reagent management systems is enhancing laboratory efficiency and reducing operational costs. Additionally, the growing use of H&E-stained slides in digital pathology, artificial intelligence (AI)-assisted image analysis, and computational pathology applications is creating new growth opportunities. Rising demand for consistent staining quality, improved tissue morphology preservation, and compatibility with whole-slide imaging systems is further supporting the segment's expansion.

The disease diagnostics segment accounted for a significant share of the slide stainer market by application in 2025.

Based on application, the slide stainers market is segmented into disease diagnostics (breast cancer, gastric cancer, lymphoma, prostate cancer, non-small cell lung cancer, other diseases) and medical research. Disease diagnostics held the largest share of the slide stainers market in 2025. The disease diagnostics segment of the global slide stainers market is growing steadily, driven by the increasing adoption of precision diagnostics, expanding applications of tissue-based biomarker analysis, and growing demand for advanced pathological examination techniques. The rising use of immunohistochemistry (IHC), in situ hybridization (ISH), and multiplex staining technologies is enabling more accurate disease classification, tumor characterization, and treatment selection. Increasing integration of automated slide staining systems with digital pathology platforms and artificial intelligence (AI)-assisted diagnostic tools is improving workflow efficiency, diagnostic consistency, and clinical decision-making.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=134046412

The Asia Pacific market is projected to register the highest growth in the market during the forecast period.

The Asia Pacific slide stainers market is expected to grow significantly, driven by expanding healthcare infrastructure, rising investments in advanced pathology laboratories, and the growing adoption of automated diagnostic technologies across China, Japan, India, South Korea, and Australia. Rising demand for cancer screening, precision oncology, and tissue-based biomarker testing is accelerating the adoption of advanced slide-staining systems, particularly for immunohistochemistry (IHC), hematoxylin and eosin (H&E), and special staining applications. China and India are seeing increased investment in diagnostic laboratory modernization, while Japan and South Korea are focusing on high-throughput automation, digital pathology integration, and advanced staining technologies. Additionally, the expansion of private diagnostic laboratory networks, a growing emphasis on early disease detection, and the adoption of standardized staining protocols are supporting regional market growth. Government initiatives to improve healthcare access, rising medical research activity, and growing demand for efficient pathology workflows are further creating growth opportunities for slide stainer manufacturers across Asia Pacific.

Key Players

Leading players in the Slide Stainers companies include Thermo Fisher Scientific Inc. (US), Agilent Technologies (US), among others.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=134046412

Slide Stainer Market - Investment and Funding Scenario

Investment Funding Context

The slide stainers market is supported by rising investments across the broader healthcare, clinical diagnostics, oncology, histopathology, biotechnology, and life sciences research ecosystems. Growing capital allocation toward cancer diagnostics, precision medicine, biomarker discovery, and molecular pathology is driving demand for advanced automated slide staining systems, immunohistochemistry (IHC) platforms, and specialized staining reagents. Rising investments in hospital pathology laboratories, diagnostic infrastructure, and cancer research facilities are further accelerating the adoption of high-throughput, precise, and reproducible tissue-staining technologies.

Investments in laboratory automation infrastructure, digital pathology platforms, AI-enabled diagnostic technologies, and advanced tissue processing systems are expanding market opportunities. Funding for cancer screening programs, companion diagnostics, translational research, and personalized medicine is encouraging laboratories to replace conventional manual staining methods with automated and semi-automated slide-staining systems. These technologies improve staining consistency, reduce manual intervention, minimize processing errors, enhance laboratory productivity, and support standardized diagnostic workflows.

Revenue Shift Context

The slide stainers market is gradually shifting revenue from conventional manual staining equipment and basic reagents toward automated slide-staining systems, advanced IHC platforms, and integrated histopathology solutions. Hospitals, diagnostic laboratories, and research institutions increasingly prioritize automated staining technologies that deliver higher throughput, improved staining accuracy and reproducibility, shorter turnaround times, and compatibility with digital pathology workflows. Growing demand for cancer diagnostics and biomarker-based testing further supports revenue growth in automated tissue-staining platforms and specialized diagnostic reagents.

Manual slide staining equipment, conventional hematoxylin and eosin (H&E) stains, and routine histological reagents continue to account for a significant share of market demand because of their widespread use across hospitals, diagnostic laboratories, academic institutions, and research facilities. However, revenue growth opportunities are increasingly concentrated in automated IHC staining systems, special staining platforms, multiplex staining technologies, companion diagnostic assays, and high-value antibodies, probes, and staining consumables. The shift toward advanced staining technologies is further supported by rising demand for integrated laboratory software, automated reagent management, digital pathology connectivity, workflow standardization, and quality control capabilities. Additionally, recurring revenue from proprietary staining reagents, antibodies, detection kits, and consumables is becoming an important component of manufacturers' business models as laboratories transition to automated, high-throughput, and digitally connected pathology workflows.

Mergers and Acquisitions

Mergers and acquisitions in the slide stainers market have remained strategically focused on expanding automated tissue-staining portfolios, strengthening immunohistochemistry (IHC) and in situ hybridization (ISH) capabilities, and integrating advanced digital pathology and AI-enabled diagnostic technologies. Recent transactions reflect the industry's growing emphasis on comprehensive histopathology workflows, companion diagnostics, biomarker analysis, and precision oncology solutions rather than standalone slide-staining equipment. These strategic developments are enabling companies to strengthen their technological capabilities, expand their geographic presence, and enhance their competitive positioning in the global slide stainers market.

SLIDE STAINERS MARKET: MERGERS AND ACQUISITIONS, JANUARY 2024–SEPTEMBER 2026

Company Revenue Share Details

The global slide stainers market comprises multinational diagnostic equipment manufacturers, specialized histopathology companies, and providers of automated tissue-staining solutions. Key players include F. Hoffmann-La Roche Ltd., Danaher Corporation, Agilent Technologies, Epredia, Sakura Finetek, Thermo Fisher Scientific, and Bio-Rad Laboratories.

The market is relatively concentrated among leading manufacturers of automated staining systems, while smaller companies compete in staining reagents, antibodies, consumables, and specialized histopathology solutions. Growing demand for cancer diagnostics, immunohistochemistry (IHC), and in situ hybridization (ISH) is intensifying market competition.

Competitive positioning is primarily driven by staining accuracy, automation capabilities, throughput, reagent compatibility, and digital pathology integration. Companies that offer integrated staining platforms, comprehensive reagent portfolios, and companion diagnostic solutions are well-positioned to capture higher-value market opportunities.

Browse Adjacent Market: Analytical and Scientific Instrumentation Market Research Reports &Consulting

See More Latest Medical Devices Reports:

Hematology Analyzers and Reagents Market by Product [Instrument (PoC,5-part 6 part), Reagents, Slide Stainers] & Service, Price (High, Mid, Low), Application (Infectious Diseases, Blood Cancer), End User (Hospital, CTL, Govt Lab) Global Forecast to 2031

Tissue Diagnostics Market by Product (Consumables [Antibodies, Kits, Reagents, Probes], Instruments [Systems, Scanner], Software, Services), Technology (ISH, IHC, Slide Staining), Disease Type (Breast Cancer, Lymphoma, Prostate Cancer) - Global Forecast to 2030

About MarketsandMarkets™  

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

MarketsandMarkets™ SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/slide-stainer-market.asp
Content Source: https://www.marketsandmarkets.com/PressReleases/slide-stainer.asp